81864-62-2

Usage

Uses

Used in Pharmaceutical Industry:
10-nitro-2,6-dioxabicyclo[5.4.0]undeca-8,10,12-trien-9-amine is used as a key intermediate in the synthesis of various pharmaceuticals for its potential to contribute to the development of new drugs. Its unique structure and reactivity make it a promising candidate for creating novel therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 10-nitro-2,6-dioxabicyclo[5.4.0]undeca-8,10,12-trien-9-amine is utilized as a building block for the design and synthesis of bioactive compounds. Its chemical properties allow for the creation of molecules with potential therapeutic effects.
Used in Organic Synthesis:
10-nitro-2,6-dioxabicyclo[5.4.0]undeca-8,10,12-trien-9-amine is used as a versatile reagent in organic synthesis, enabling the creation of a wide range of chemical compounds for various applications, including but not limited to, the development of new materials and chemical products.
Used in Material Science:
In material science, 10-nitro-2,6-dioxabicyclo[5.4.0]undeca-8,10,12-trien-9-amine is employed as a component in the development of new materials, leveraging its chemical properties to enhance material characteristics such as stability, reactivity, or other desired properties.
Research and Development:
10-nitro-2,6-dioxabicyclo[5.4.0]undeca-8,10,12-trien-9-amine is also used in research and development settings to explore its potential applications and to understand its chemical behavior, which can lead to innovative uses in various industries.

InChI:InChI=1/C9H10N2O4/c10-6-4-8-9(5-7(6)11(12)13)15-3-1-2-14-8/h4-5H,1-3,10H2

Upstream product

• 81864-61-1 7-acetamino-8-nitro-3,4-dihydro-2H-1,5-benzodioxepine 
• 135399-50-7 7,8-dinitro-3,4-dihydro-2H-benzo<1,4>dioxepin 

Relevant academic research and scientific papers

Quinoxaline compound, preparation method and application of quinoxaline compound in medicine

The invention provides a quinoxaline compound, a preparation method and application of the quinoxaline compound in medicine, and particularly relates to a quinoxaline compound with PAR4 antagonistic activity, a preparation method of the quinoxaline compound, a pharmaceutical composition containing the quinoxaline compound and application of the quinoxaline compound. Specifically, the invention provides a compound shown as a general formula I and/or II or a tautomer or pharmaceutically acceptable salt thereof, a preparation method of the compound, and application of the compound or the tautomer or the pharmaceutically acceptable salt in medicines for preventing and/or treating thromboembolic diseases.

Derivatives of 3,4-Dihydro-2H-benzodioxepin. Preparation of 7,8-6H-dioxepino-2,1,3-benzoxadiazole 1-Oxide.

A novel annelated benzofuroxan 4 and a benzofurazan 4a have been prepared in good yields.Nitration of 5 afforded both trinitro derivatives 6 and 7.Low temperature nmr spectroscopy was applied on compound 4 and the value ΔG* is reported.

Imidazole derivatives

Tricyclic imidazole derivatives of the formula STR1 wherein R1 is 2-pyridyl optionally substituted by lower alkyl or lower alkoxy, n is the integer 0 or 1, R2 is hydrogen or lower alkyl, R3 and R4, independently, are hydrogen or lower alkyl, A is a group of the formula STR2 m is the integer 2 or 3, R5, R6, R7 and R8, independently, are hydrogen or lower alkyl, and R9 is hydrogen and R10 is hydrogen or lower alkyl or R9 and R10 taken together are oxo, provided that at least one of R3 and R4 is lower alkyl when A is a group of the formula and their pharmaceutically acceptable acid addition salts. The compounds of formula I inhibit gastric acid secretion and prevent the formation of gastric ulcers.